Go to main content

Press Releases

Explore the archived press releases about AOP Health, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via aop-health@aoporphan.com 

Austria as a Research & Development base

31. 8. 2017

AOP in Press: "New Therapies To Struggle Against Established Hematology"

11. 7. 2017

AOP and PharmaEssentia announce latest clinical results for Ropeginterferon alfa-2b in Polycythemia Vera

23. 6. 2017

AOP Orphan Pharmaceuticals AG and Amomed Pharma GmbH announce the launch of RAPIBLOC® (Landiolol) in Germany and Austria.

19. 6. 2017

Rare Diseases: AOP Orphan Pharmaceuticals AG invests in sustainable Research & Development

16. 5. 2017

Miroslaw Jan Lubecki – newly appointed Chief of Commercial Operations

12. 4. 2017